How much funding has HMNC Brain Health raised?

HMNC Brain Health has raised $74.6M in total funding, most recently a Series B round.

Who are HMNC Brain Health's investors?

HMNC Brain Health's investors include MEDICE.

Where is HMNC Brain Health headquartered?

HMNC Brain Health is headquartered in Munich, Germany.

What industry is HMNC Brain Health in?

HMNC Brain Health operates in Biotech.

How many employees does HMNC Brain Health have?

HMNC Brain Health has 11-50 employees.

HMNC Brain Health

Pioneering Precision Psychiatry

Munich, Germany · $74.6M raised

Biotech

Headquarters: Munich
Employees: 11–50
Business Model: B2B
Website: hmnc-brainhealth.com

Total Funding: $74.6M
Last Round: $50.0M Series BJun 2026
Rounds: 3

About

HMNC Brain Health is a disruptive clinical-stage biopharma company pioneering Precision Psychiatry, powered by its own AI Platform, with a focus on Treatment-Resistant Depression (TRD) and Major Depressive Disorder (MDD). The company combines Psychiatry, Genomics, and Analytics to develop innovative, targeted therapies for mental health disorders. Its Precision Psychiatry approach, built on more than 30 years of research, addresses the high unmet medical need created by today's non-specific and often insufficient antidepressant treatments.

Summary

HMNC Brain Health is a Biotech company based in Munich, Germany. It has raised $74.6M in total across 3 rounds, most recently a $50.0M Series B round in Jun 2026. Investors include MEDICE.